Amend Surgical has entered into an exclusive worldwide licensing agreement with MLM Biologics to advance development of its NanoFUSE® Bioactive Plug, a regenerative solution being developed to support bone growth and reduce complications following tooth extractions.
The NanoFUSE® Bioactive Plug combines pro-regenerative and antimicrobial properties in a single solution designed to support healing and protect the surgical site during socket preservation procedures.
Under the agreement, Amend Surgical has secured exclusive global rights to MLM Biologics’ proprietary collagen technology, manufacturing processes and related technical expertise for dental applications.
Also read: Kenya Urged to Include Analogue Insulin Pens in Health Benefits Package
“This milestone represents an important step in our strategy to build a comprehensive regenerative dentistry platform,” said Robby Lane, Chief Executive Officer and Co-Founder of Amend Surgical. “As we continue to bring together complementary technologies, we are expanding our ability to address key clinical needs, creating value for clinicians, patients, and future partners.”
The licensed technology will support development of the NanoFUSE Bioactive Plug and may enable additional applications across the company’s regenerative dentistry portfolio.
The new product complements existing solutions including NanoFUSE® Bioactive Matrix and Amend Tissue Tape®, expanding the platform across bone regeneration, socket preservation, soft-tissue management and infection control.
Click here to join our WhatsApp channel here
MLM Biologics will manufacture intermediate product for Amend Surgical during the first five years of the agreement and provide support for product development, regulatory activities and commercial scale-up.
“We’re pleased to partner with Amend Surgical as they advance the development of the NanoFUSE Bioactive Plug,” said Chandra Nataraj, PhD, Chief Executive Officer of MLM Biologics. “It represents an exciting application of our technology, and we believe this collaboration creates a strong foundation for innovation that can benefit clinicians and patients alike.”
